Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-18

Clinical Trial Update: Post-Approval Study With the KAMRA Inlay

View source ↗

Summary

Post-approval study update for the KAMRA Inlay addressing presbyopia. The document lists the trial status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KAMRA inlay (corneal inlay)

Snippet

Sponsor: AcuFocus, Inc. | Conditions: Presbyopia | Status: UNKNOWN